99 related articles for article (PubMed ID: 1373318)
1. Amplification of the topoisomerase II alpha gene in a non-small cell lung cancer cell line and characterisation of polymorphisms at the human topoisomerase II alpha and beta loci in normal tissue.
Keith WN; Tan KB; Brown R
Genes Chromosomes Cancer; 1992 Mar; 4(2):169-75. PubMed ID: 1373318
[TBL] [Abstract][Full Text] [Related]
2. Expression of topoisomerase II alpha and beta in an adenocarcinoma cell line carrying amplified topoisomerase II alpha and retinoic acid receptor alpha genes.
Coutts J; Plumb JA; Brown R; Keith WN
Br J Cancer; 1993 Oct; 68(4):793-800. PubMed ID: 8398710
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung.
Giaccone G; van Ark-Otte J; Scagliotti G; Capranico G; van der Valk P; Rubio G; Dalesio O; Lopez R; Zunino F; Walboomers J
Biochim Biophys Acta; 1995 Dec; 1264(3):337-46. PubMed ID: 8547322
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase II alpha content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell lines.
Yamazaki K; Isobe H; Hanada T; Betsuyaku T; Hasegawa A; Hizawa N; Ogura S; Kawakami Y
Cancer Chemother Pharmacol; 1997; 39(3):192-8. PubMed ID: 8996519
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of DNA topoisomerase II alpha and II beta genes between small cell and non-small cell lung cancer.
Syahruddin E; Oguri T; Takahashi T; Isobe T; Fujiwara Y; Yamakido M
Jpn J Cancer Res; 1998 Aug; 89(8):855-61. PubMed ID: 9765623
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous quantitation of topoisomerase II alpha and beta isoform mRNAs in lung tumor cells and normal and malignant lung tissue.
Mirski SE; Voskoglou-Nomikos T; Young LC; Deeley RG; Campling BG; Gerlach JH; Cole SP
Lab Invest; 2000 Jun; 80(6):787-95. PubMed ID: 10879730
[TBL] [Abstract][Full Text] [Related]
7. Two COOH-terminal truncated cytoplasmic forms of topoisomerase II alpha in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicing.
Yu Q; Mirski SE; Sparks KE; Cole SP
Biochemistry; 1997 May; 36(19):5868-77. PubMed ID: 9153428
[TBL] [Abstract][Full Text] [Related]
8. Reduced topoisomerase II activity in multidrug-resistant human non-small cell lung cancer cell lines.
Eijdems EW; de Haas M; Timmerman AJ; Van der Schans GP; Kamst E; de Nooij J; Astaldi Ricotti GC; Borst P; Baas F
Br J Cancer; 1995 Jan; 71(1):40-7. PubMed ID: 7819046
[TBL] [Abstract][Full Text] [Related]
9. Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression.
Giaccone G; Gazdar AF; Beck H; Zunino F; Capranico G
Cancer Res; 1992 Apr; 52(7):1666-74. PubMed ID: 1312895
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase II alpha co-amplification with erbB2 in human primary breast cancer and breast cancer cell lines: relationship to m-AMSA and mitoxantrone sensitivity.
Smith K; Houlbrook S; Greenall M; Carmichael J; Harris AL
Oncogene; 1993 Apr; 8(4):933-8. PubMed ID: 8096076
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a topoisomerase II gene rearrangement in a human small-cell lung cancer cell line.
Binaschi M; Giaccone G; Gazdar AF; De Isabella P; Ricotti GC; Capranico G; Zunino F
J Natl Cancer Inst; 1992 Nov; 84(22):1710-6. PubMed ID: 1331483
[TBL] [Abstract][Full Text] [Related]
12. Comparison of DNA topoisomerase II alpha expression in small cell and nonsmall cell carcinoma of the lung. In search of a mechanism of chemotherapeutic response.
Guinee DG; Holden JA; Benfield JR; Woodward ML; Przygodzki RM; Fishback NF; Koss MN; Travis WD
Cancer; 1996 Aug; 78(4):729-35. PubMed ID: 8756364
[TBL] [Abstract][Full Text] [Related]
13. Higher expression of topoisomerase II in lung cancers than normal lung tissues: different expression pattern from topoisomerase I.
Hasegawa T; Isobe K; Nakashima I; Shimokata K
Biochem Biophys Res Commun; 1993 Aug; 195(1):409-14. PubMed ID: 8395833
[TBL] [Abstract][Full Text] [Related]
14. Co-amplification of erbB2, topoisomerase II alpha and retinoic acid receptor alpha genes in breast cancer and allelic loss at topoisomerase I on chromosome 20.
Keith WN; Douglas F; Wishart GC; McCallum HM; George WD; Kaye SB; Brown R
Eur J Cancer; 1993; 29A(10):1469-75. PubMed ID: 8104440
[TBL] [Abstract][Full Text] [Related]
15. Altered topoisomerase II alpha in a drug-resistant small cell lung cancer cell line selected in VP-16.
Mirski SE; Evans CD; Almquist KC; Slovak ML; Cole SP
Cancer Res; 1993 Oct; 53(20):4866-73. PubMed ID: 8104687
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of DNA topoisomerase II confers resistance to etoposide (VP-16) in small cell lung cancer cell lines established from a refractory tumor of a patient and by in vitro selection.
Andoh T; Nishizawa M; Hida T; Ariyoshi Y; Takahashi T; Ueda R
Oncol Res; 1996; 8(6):229-38. PubMed ID: 8895198
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay.
Withoff S; Smit EF; Meersma GJ; van den Berg A; Timmer-Bosscha H; Kok K; Postmus PE; Mulder NH; de Vries EG; Buys CH
Lab Invest; 1994 Jul; 71(1):61-6. PubMed ID: 8041119
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of the topoisomerase II alpha gene and its expression in human ovarian cancer.
van der Zee AG; de Vries EG; Hollema H; Kaye SB; Brown R; Keith WN
Ann Oncol; 1994 Jan; 5(1):75-81. PubMed ID: 8172796
[TBL] [Abstract][Full Text] [Related]
19. Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase.
Lefevre D; Riou JF; Ahomadegbe JC; Zhou DY; Benard J; Riou G
Biochem Pharmacol; 1991 Jun; 41(12):1967-79. PubMed ID: 1645555
[TBL] [Abstract][Full Text] [Related]
20. Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.
Järvinen TA; Tanner M; Bärlund M; Borg A; Isola J
Genes Chromosomes Cancer; 1999 Oct; 26(2):142-50. PubMed ID: 10469452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]